The impact of single gene testing (SGT) on subsequent comprehensive genomic profiling (CGP) success in community oncology practice for advanced non-small cell lung cancer (NSCLC): Results from a prospective observational reference laboratory testing program

被引：0
作者：
Nesline, Mary K.
DePietro, Paul
Cooper, Maureen
Zhang, Shengle
Howarth, Sarah
Wallen, Zachary D.
Biorn, Michael D.
Strickland, Kyle C.
Previs, Rebecca A.
Ko, Heidi Chwan
Sausen, Mark
Jackson, Jennifer B.
Saini, Kamal S.
Wise, Scott
Jensen, Taylor J.
Pabla, Sarabjot
Conroy, Jeffrey M.
Reddy, Prasanth
Severson, Eric A.
Ramkissoon, Shakti
机构：
[1] Labcorp Oncol, Durham, NC USA
[2] Labcorp Oncol, Buffalo, NY USA
[3] Labcorp, Buffalo, NY USA
[4] Duke Univ, Duke Canc Inst, Dept Pathol, Med Ctr, Durham, NC USA
[5] Duke Univ, Duke Canc Inst, Div Gynecol Oncol, Dept Obstet & Gynecol,Med Ctr, Durham, NC USA
[6] Personal Genome Diagnost, Labcorp, Baltimore, MD USA
[7] LabCorp, Ann Arbor, MI USA
[8] OmniSeq, Labcorp, Buffalo, NY USA
[9] OmniSeq Inc, Labcorp, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6506
引用
收藏
页数：1
相关论文
共 35 条
[31]   Testing for and frequency of EGFR and ALK alterations in patients with early and locally advanced non-small cell lung cancer in Germany. Results from the prospective German Registry CRISP (AIO-TRK-0315) [J].
Eberhardt, W. E. E. ;
Thomas, M. ;
Stuschke, M. ;
de Wit, M. ;
Seese, B. ;
Spring, L. ;
Andres-Pons, A. ;
Janicke, M. ;
Vahtrick, O. ;
Ludwig, P. ;
Hipper, A. ;
Hoffknecht, P. ;
von der Heyde, E. ;
Sebastian, M. ;
Groeschel, A. ;
Passlick, B. ;
Griesinger, F. .
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 :10-11
[32]   Effect of Sample Type and Turnaround Time (TAT) on the Feasibility of Non-Small Cell Lung Cancer (NSCLC) Epidermal Growth Factor Receptor (EGFR) Mutation Testing in Routine Clinical Practice: Results From the Spanish REASON Study [J].
Gracia, M. ;
Majem, M. ;
Martinez Aguillo, M. T. ;
Martinez Banaclocha, N. ;
Provencio, M. ;
Arriola, E. ;
Codes, M. ;
Artal, A. ;
Cajal, R. ;
Massuti Sureda, B. .
EUROPEAN JOURNAL OF CANCER, 2011, 47 :S255-S255
[33]   The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2nd/3rd-Generation ALK Tyrosine Kinase Inhibitors (TKIs) [J].
Raphael, Ari ;
Onn, Amir ;
Holtzman, Liran ;
Dudnik, Julia ;
Urban, Damien ;
Kian, Waleed ;
Cohen, Aharon Y. ;
Moskovitz, Mor ;
Zer, Alona ;
Bar, Jair ;
Rabinovich, Natalie Maimon ;
Grynberg, Shirly ;
Oedegaard, Cecilie ;
Agbarya, Abed ;
Peled, Nir ;
Shochat, Tzippy ;
Dudnik, Elizabeth .
FRONTIERS IN ONCOLOGY, 2022, 12
[34]   COMPREHENSIVE GENOMIC TESTING IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A COST-EFFECTIVENESS ANALYSIS OF PLASMA-BASED CIRCULATING TUMOR DNA (CTDNA) NEXT-GENERATION SEQUENCING (NGS) TO INFORM FIRST-LINE TREATMENT DECISIONS [J].
Lopes, G. ;
Liu, E. ;
Raymond, V ;
Scott, J. ;
Ho, V ;
Gandara, D. .
VALUE IN HEALTH, 2020, 23 :S326-S326
[35]   Routine use of a modest next generation sequencing panel provides additional clinically useful data beyond single gene testing in non-small cell lung cancer and is fit for purpose as a clinical assay: Collated data from a single molecular diagnostic laboratory. [J].
Moore, David Allan ;
Balbi, Kevin ;
Arkenau, Hendrik-Tobias ;
Bennett, Philip .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
1234